[144] ESAB Corporation SEC Filing

Rhea-AI Filing Summary

Form 144 notice by an insider of ESAB Corporation (ESAB) indicates a proposed sale of common shares through Fidelity Brokerage Services on the NYSE. The filing shows 2,369 shares proposed for sale with an aggregate market value of $277,466.45, against 60,698,710 shares outstanding. The planned approximate sale date is 08/22/2025. The securities were acquired mainly through restricted stock vesting on 02/17/2025 (1,111 shares) and 05/12/2025 (1,020 shares), and an option exercise dated 03/08/2023 with cash payment scheduled 08/22/2025 (238 shares). The filer certifies no undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: Routine insider sale notice; size is immaterial versus outstanding shares.

The Form 144 documents an insider's proposed sale of 2,369 common shares valued at $277,466.45, scheduled for 08/22/2025 via Fidelity on the NYSE. Relative to 60.7 million shares outstanding, the sale represents a de minimis fraction of equity and is consistent with dispositions of recently vested restricted stock and option-related shares. There are no reported prior sales in the past three months. From a market-impact perspective this filing is likely neutral; it serves primarily as a compliance disclosure under Rule 144.

Corporate Governance Expert

TL;DR: Compliance-focused disclosure; confirms vesting and option settlement as sources of shares.

The notice details acquisition types—restricted stock vesting and an option grant—supporting that proceeds derive from compensation and option exercise. The filer affirms no undisclosed material adverse information and references Rule 10b5-1 plan language but does not state a plan adoption date. This filing raises no immediate governance red flags but lacks any indication of a trading plan date if one exists, which would clarify intent and timing under insider-trading frameworks.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	2369	277466.45	60698710	08/22/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/17/2025	Restricted Stock Vesting	Issuer			1111	02/17/2025	Compensation
Common	05/12/2025	Restricted Stock Vesting	Issuer			1020	05/12/2025	Compensation
Common	08/22/2025	Option Granted - 03/08/2023	Issuer			238	08/22/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the ESAB (ESAB) Form 144 disclose?

It discloses a proposed sale of 2,369 common shares via Fidelity on NYSE with aggregate value $277,466.45 and an approximate sale date of 08/22/2025.

How many shares outstanding does ESAB report in the filing?

The filing lists 60,698,710 shares outstanding, which provides context for the proposed 2,369-share sale.

What were the sources of the shares to be sold according to the filing?

Securities were acquired via restricted stock vesting (02/17/2025 and 05/12/2025) and an option-related grant with cash payment scheduled 08/22/2025.

Does the Form 144 report any sales in the past three months?

No. The filing states 'Nothing to Report' for securities sold during the past three months by the person for whose account the securities are to be sold.

Does the filer state any undisclosed material information or a 10b5-1 plan date?

The filer represents they do not know any undisclosed material adverse information, and the filing references trading plans generally but does not provide a specific 10b5-1 plan adoption date.